Model N director Kimberly DeCarlis sells shares worth over $12k By

© Reuters.

Model N, Inc. (NYSE:) director Kimberly DeCarlis has sold 500 shares of company stock, a transaction that amounted to over $12,000, according to a recent SEC filing. The shares were sold at a price of $25.63 each, reflecting a single-day sale based on the provided information.

The transaction was executed under a pre-arranged trading plan, known as a Rule 10b5-1 plan, which DeCarlis had adopted on December 14, 2023. Such plans allow insiders to sell shares at predetermined times to avoid accusations of trading on nonpublic information.

Following the sale, DeCarlis still retains 18,115 shares of Model N, indicating a continued investment in the company’s future. Model N, headquartered in San Mateo, California, specializes in cloud-based revenue management solutions for the life sciences and technology industries.

This sale comes at a time when insider transactions are closely watched by investors seeking insights into a company’s health and the confidence of its key executives and directors in the business’s prospects. While the reasons for DeCarlis’s sale were not disclosed, the use of a Rule 10b5-1 plan suggests that the decision was part of a structured financial strategy.

Model N, with its focus on software solutions, plays a pivotal role in the digital transformation strategies of its clients. The company’s performance is closely tied to the broader technology sector, which has experienced significant volatility in recent times.

Investors and market watchers often monitor insider sales for hints about a company’s internal expectations. However, it is important to note that such transactions do not always provide clear signals and can be influenced by a variety of personal financial considerations.

Model N’s stock performance and further insider transactions will continue to be areas of interest for shareholders and potential investors as they assess the company’s position within the competitive tech landscape.

InvestingPro Insights

Model N, Inc. (NYSE:MODN) has been navigating a challenging market, as reflected in the recent insider sale by director Kimberly DeCarlis. For investors looking for additional context, InvestingPro provides a deeper dive into the company’s financial health and market performance.

According to InvestingPro data, Model N currently holds a market capitalization of $976.2 million. Despite the company’s negative P/E ratio of -30.84, which suggests investors are wary of its earnings potential, analysts are forecasting a brighter horizon. An InvestingPro Tip highlights that net income is expected to grow this year, which could signal a turnaround from the previous twelve months where the company was not profitable. Additionally, the company’s liquid assets exceed its short-term obligations, indicating a solid financial footing that may reassure investors about its ability to manage cash flow and meet immediate liabilities.

However, not all signals are equally positive. Another InvestingPro Tip indicates that 11 analysts have revised their earnings estimates downwards for the upcoming period, which may raise concerns about the company’s near-term performance. Moreover, while the company’s revenue has grown by 11.92% over the last twelve months as of Q1 2024, it is also trading at a high Price/Book multiple of 7.98, suggesting that the stock might be priced optimistically relative to its book value.

For those interested in further InvestingPro Tips, there are additional insights available, including the company’s debt levels, valuation multiples, and profitability predictions for the year. Model N’s comprehensive financial analysis can be found at InvestingPro. Subscribers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking a total of 9 InvestingPro Tips to help inform their investment decisions.

As shareholders and potential investors consider Model N’s future, these insights can provide a more nuanced understanding of the company’s financial health and market valuation. The upcoming earnings date on May 7, 2024, will be a key event to watch for further clarity on the company’s trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.


This website uses cookies. By continuing to use this site, you accept our use of cookies.